January 2023

Pharmacists want you to be on time.

The FDA approved a new azole antifungal for recurrent vulvovaginal candidiasis.

Case studies address questions about a patient with type 2 diabetes and a patient who is curious about nicotine replacement therapy.

Protect patients by evaluating VIGIV concentration and avoiding tearing of metal flange on vaccine vial.

Cases address questions about glycated hemoglobin A1C and hypoglycemia management.

Compassionate use bridges gap between safety and patients' immediate need for biologics, devices, drugs, devices on spearhead of research and development.

Products include drugs for patients with stroke, bacterial infections, and acute pain.

Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?

These diagnostic tests play critical role in chronic disease management, early interventions, and emergency situations.

Zilucoplan is among highlighted products of the month.

Educating patients, posting on social media, and countering misinformation are critical strategies.

November 27, 2023, marks date set by statute for full implementation of Drug Supply Chain Security Act.

Products range from natural eye relief to sleep aid.

Federal court weighs whether termination that followed was aged-based discrimination under state's Human Rights Act.

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

Counseling sessions offer opportunity to educate about appropriate dosing, potential adverse effects.

Clogged or inflamed sinuses spell misery, but many products can relieve the pain and pressure.

Workload, work-life balance, and management continue to be the top 3 drivers of job dissatisfaction.

After not paying attention, looking other way for years, is the pharmacy industry letting patients down again by employing crude methods of controlled substances monitoring?

Cases of COVID-19, influenza, and respiratory syncytial virus are creating a so-called tripledemic.